Oncimmune Holdings Faces Administration and Delisting
Why we think this is very bad
This announcement from Oncimmune Holdings is extremely negative, with the company unable to secure a buyer for its main trading subsidiary or raise additional capital to meet its funding needs. As a result, the Board has concluded that the Group should be placed into administration, and trading in the company's shares on AIM will be suspended. This is a very serious situation for the business, with the company facing delisting and administration, which will likely result in significant losses for shareholders.
Key Points
- Unable to secure a buyer for Oncimmune Germany GmbH
- Failed to raise additional capital to meet funding needs
- Company to be placed into administration
- Trading in shares suspended from 17 March 2025
Summary
Oncimmune Holdings plc (AIM: ONC.L) has announced that it has been unable to secure a buyer for its trading subsidiary, Oncimmune Germany GmbH, or raise the additional capital required to meet its short-term funding needs. As a result, the Board has concluded that the Group should be placed into administration in order to preserve the value of the business for creditors. Trading in the company's shares on AIM will be suspended from 7:30am on 17 March 2025.